Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Norovirus-Specific Memory T Cell Responses in Adult Human Donors

3 Oct 2016

Abstract excerpt

Norovirus (NoV) is a leading cause of acute gastroenteritis in people of all ages worldwide. NoV specific serum antibodies which block the binding of NoV virus-like particles (VLPs) to the cell receptors have been thoroughly investigated. In contrast, only a few publications are available on the NoV capsid VP1 protein-specific T cell responses in humans naturally infected with the virus. Freshly isolated...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Animal Virus Infections Studies
Share to Viral gastroenteritis research and epidemiology
Share to Viral Infections and Immunology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27752254
DOI: 10.3389/fmicb.2016.01570

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Norovirus-Specific Memory T Cell Responses in Adult Human DonorsPMID 27752254Read ↗

Functionality and avidity of norovirus-specific antibodies and T cells induced by GII.4 virus-like particles alone or co-administered with different genotypes.Semantic proximity Read ↗

Variable and conserved B cell epitopes of GII.4 human noroviruses.Semantic proximity Read ↗

Characterization of the homo- and heterotypic immune responses after natural norovirus infection.Semantic proximity Read ↗

A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like particle vaccineSemantic proximity Read ↗

Norovirus Immunity and the Great EscapeSemantic proximity Read ↗

Generation and characterization of nucleic acid aptamers targeting the capsid P domain of a human norovirus GII.4 strainSemantic proximity Read ↗

Safety and Immunogenicity of Different Formulations of Norovirus Vaccine Candidate in Healthy Adults: A Randomized, Controlled, Double-Blind Clinical Trial.Semantic proximity Read ↗

Pre-existing immunity to norovirus GII-4 virus-like particles does not impair de novo immune responses to norovirus GII-12 genotype.Semantic proximity Read ↗

A broadly protective human antibody for GI genogroup norovirusesSemantic proximity Read ↗

Llama Nanoantibodies with Therapeutic Potential against Human Norovirus DiarrheaSemantic proximity Read ↗

The Antigenic Topology of Norovirus as Defined by B and T Cell Epitope Mapping: Implications for Universal Vaccines and TherapeuticsSemantic proximity Read ↗

Intranasal vaccination with an adjuvanted Norwalk virus-like particle vaccine elicits antigen-specific B memory responses in human adult volunteers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.